This inventor holds 2 USPTO granted patents and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignee: Kyowa Kirin Co., Ltd.. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2022
Title: Toshihiro Seike: Innovator in Anticancer Compounds
Introduction
Toshihiro Seike is a notable inventor based in Chiyoda-ku, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with anticancer properties. With a total of 2 patents, his work continues to impact the medical community.
Latest Patents
Seike's latest patents focus on the creation of α,β-unsaturated amide compounds. These compounds are designed to possess anticancer activity and are represented by specific chemical formulas. The invention provides a pharmaceutically acceptable salt or similar derivatives that can be utilized in cancer treatment.
Career Highlights
Throughout his career, Toshihiro Seike has been associated with Kyowa Kirin Co., Ltd., a prominent company in the pharmaceutical industry. His work has been instrumental in advancing the understanding and application of anticancer compounds.
Collaborations
Seike has collaborated with notable colleagues, including Tomohiro Danjo and Katsuaki Fujiwara. These partnerships have fostered innovation and contributed to the success of their projects.
Conclusion
Toshihiro Seike's contributions to the field of pharmaceuticals, particularly in anticancer research, highlight his role as an influential inventor. His ongoing work continues to pave the way for advancements in cancer treatment.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile